U.S. Food and Drug Administration requests that Opana ER (oxymorphone hydrochloride) is withdrawn from the market due to risk of abuse.
Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
- LATEST in Health - Therapists Are Taking MDMA To Learn How To Treat PTSD
- LATEST in Justice & Law - In These States, Past Marijuana Crimes Can Go Away
- LATEST in Culture - Malcolm Young, AC/DC Guitarist and Co-Founder, Dead at 64
- LATEST in Health - Unfounded Pot Hysteria Spreads on the Internet
- LATEST in Health - Ohio councilman: After 2 overdoses, no more EMS
- LATEST in Culture - Sexual Harrassment in AA.
- LATEST in Justice & Law - New Orleans man locked up nearly 8 years awaiting trial, then drug case gets tossed
- LATEST in Health - Kratom Products Can Kill You, FDA Says
- LATEST in Health - Can Marijuana Help Addicts Kick Opioids?
- LATEST in Miscellaneous - The God Capsule: Can Psychedelics Prove a Biological Basis for Spirituality?